Dr. Eric Chenven

Probably prostate cancer is the number one cancer that we deal with and treat and really have taken a lot onto ourselves, which has taken a little bit of getting used to, I think. Truly, you have become the oncologist, I think, for prostate cancer, many of the others that Certainly, we involve our radiation oncology colleagues and medical oncology and so on.

But we're sort of, I think, the captains of the ship when it comes to the prostate cancer. I think we like having control over our patients and managing them all the way out to advanced disease. I still do full breadth of surgery from little stuff in the office to hospital, kidney stones and so on. I think that the robotic prostatectomies, we have one of the Dr. Gorbati in our practice.

But we're sort of, I think, the captains of the ship when it comes to the prostate cancer. I think we like having control over our patients and managing them all the way out to advanced disease. I still do full breadth of surgery from little stuff in the office to hospital, kidney stones and so on. I think that the robotic prostatectomies, we have one of the Dr. Gorbati in our practice.

But we're sort of, I think, the captains of the ship when it comes to the prostate cancer. I think we like having control over our patients and managing them all the way out to advanced disease. I still do full breadth of surgery from little stuff in the office to hospital, kidney stones and so on. I think that the robotic prostatectomies, we have one of the Dr. Gorbati in our practice.

We hired out of his robotics fellowship about 12 years ago now. He's doing all the robotics at this point in our practice. I've kind of given way to that and decreased my stress level a little bit and so on. And Nassim, how about yours?

We hired out of his robotics fellowship about 12 years ago now. He's doing all the robotics at this point in our practice. I've kind of given way to that and decreased my stress level a little bit and so on. And Nassim, how about yours?

We hired out of his robotics fellowship about 12 years ago now. He's doing all the robotics at this point in our practice. I've kind of given way to that and decreased my stress level a little bit and so on. And Nassim, how about yours?

That's a decision that I make with our radiation oncologist and it's never something that I'm telling them. I think, you know, I sort of liken them to being the surgeon as running the show with the radiation and kind of guiding me what to do and we certainly do work as a team back and forth and I think I communicate very well.

That's a decision that I make with our radiation oncologist and it's never something that I'm telling them. I think, you know, I sort of liken them to being the surgeon as running the show with the radiation and kind of guiding me what to do and we certainly do work as a team back and forth and I think I communicate very well.

That's a decision that I make with our radiation oncologist and it's never something that I'm telling them. I think, you know, I sort of liken them to being the surgeon as running the show with the radiation and kind of guiding me what to do and we certainly do work as a team back and forth and I think I communicate very well.

They they'll often text me, call me and we'll go over each of these prostate cancer patients. And I think that interestingly, we had gotten used to when I got

They they'll often text me, call me and we'll go over each of these prostate cancer patients. And I think that interestingly, we had gotten used to when I got

They they'll often text me, call me and we'll go over each of these prostate cancer patients. And I think that interestingly, we had gotten used to when I got

into practice in 2003 and we really got into doing all the IMRT, the image guided IMRT, all the stuff that we saw, thank goodness, the radiation cystitis and these people slowly bleeding to death, thank God that's really dried up quite a lot and the patients have been so happy having the radiation done.

into practice in 2003 and we really got into doing all the IMRT, the image guided IMRT, all the stuff that we saw, thank goodness, the radiation cystitis and these people slowly bleeding to death, thank God that's really dried up quite a lot and the patients have been so happy having the radiation done.

into practice in 2003 and we really got into doing all the IMRT, the image guided IMRT, all the stuff that we saw, thank goodness, the radiation cystitis and these people slowly bleeding to death, thank God that's really dried up quite a lot and the patients have been so happy having the radiation done.

They really haven't been having the tenesmus, the urgency, the diarrhea, very rare to see patients with all those with the standard IMRT, which is the eight weeks. But I think as some of the newer trials have come out in radiation oncology and not just SBRT, but moving into the hypo fractionated courses with five weeks of radiation, where again, they're pushing higher doses at each treatment.

They really haven't been having the tenesmus, the urgency, the diarrhea, very rare to see patients with all those with the standard IMRT, which is the eight weeks. But I think as some of the newer trials have come out in radiation oncology and not just SBRT, but moving into the hypo fractionated courses with five weeks of radiation, where again, they're pushing higher doses at each treatment.

They really haven't been having the tenesmus, the urgency, the diarrhea, very rare to see patients with all those with the standard IMRT, which is the eight weeks. But I think as some of the newer trials have come out in radiation oncology and not just SBRT, but moving into the hypo fractionated courses with five weeks of radiation, where again, they're pushing higher doses at each treatment.

I think that's when the spacers are really of value. But again, I think we're seeing our Radon colleagues doing a lot of hypofractionated when it comes to the IMRs.